Patents by Inventor Loic GUILLONEAU

Loic GUILLONEAU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200354387
    Abstract: The present invention relates to a process for preparing a mixture M1 of enol phosphate isomers devoid of (E,E) isomer and comprising at least 98% of (E,Z) isomer, at least 0.1% of (Z,Z) isomer and at least 0.1% of (Z,E) isomer, comprising bringing a mixture of isomers of said enol phosphate comprising a detectable amount of (E,E) isomer into contact with a hydrolysable dienophile in an organic solvent, followed by base hydrolysis of the medium obtained and elimination of the adduct formed, in order to obtain the mixture M1 devoid of (E,E) isomer.
    Type: Application
    Filed: March 9, 2018
    Publication date: November 12, 2020
    Applicants: Universite De Bordeaux, Institut Polytechnique De Bordeaux, Centre National de la Recherche Scientifique (CNRS)
    Inventors: Mathieu Pucheault, Virginie Liautard, Loic Guilloneau, Olivier Guerret
  • Patent number: 9790171
    Abstract: The subject matter of the present invention is the novel molecules of formulae E, E? and F. These molecules prove to be synthesis intermediates that are very advantageous for the manufacture of derivatives of sphingosine or of ceramides functionalized in position 1, with good yields, in which R1 and R2 are fatty chains, R3 is an alkyl group and R4 is a protective group for alcohol functions. Another subject of the invention is the use of the intermediates of type F for converting same into intermediates of type G, by means of reduction in the presence of lithium borohydride. The G molecules are precursors that are known to make it possible to obtain sphingolipids or sphingomyelin.
    Type: Grant
    Filed: January 14, 2014
    Date of Patent: October 17, 2017
    Assignee: M2I DEVELOPMENT
    Inventors: Loic Guilloneau, Samuel Dufour, Olivier Guerret
  • Publication number: 20160083335
    Abstract: The subject matter of the present invention is the novel molecules of formulae E, E? and F. These molecules prove to be synthesis intermediates that are very advantageous for the manufacture of derivatives of sphingosine or of ceramides functionalized in position 1, with good yields, in which R1 and R2 are fatty chains, R3 is an alkyl group and R4 is a protective group for alcohol functions. Another subject of the invention is the use of the intermediates of type F for converting same into intermediates of type G, by means of reduction in the presence of lithium borohydride. The G molecules are precursors that are known to make it possible to obtain sphingolipids or sphingomyelin.
    Type: Application
    Filed: January 14, 2014
    Publication date: March 24, 2016
    Applicant: M2I DEVELOPMENT
    Inventors: Loic GUILLONEAU, Samuel DUFOUR, Olivier GUERRET